---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-22-000101"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2022-09-08T23:59:59+00:00"
generated_at: "2026-06-23T13:16:52.360042+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health announces Pharmaceutical Segment CEO change; Crawford out, Weitzman in

## Summary
- Victor Crawford to step down as Pharmaceutical Segment CEO effective Sept 19, 2022; will stay until Nov 13 for transition.
- Debbie Weitzman, former President of Pharmaceutical Distribution, named new CEO of Pharmaceutical Segment.
- Role of President of Pharmaceutical Distribution eliminated; segment restructured with additional role eliminations.
- Pharmaceutical and Specialty Distribution businesses will both report directly to Weitzman.

## SEC filing metadata
- accession: 0000721371-22-000101
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2022-09-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137122000101/0000721371-22-000101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137122000101/cah-20220907.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-22-000101
- JSON: https://secwatch.observer/filing/0000721371-22-000101.json
- Plain text: https://secwatch.observer/filing/0000721371-22-000101.txt

## Key facts
- Executive change
  Victor L. Crawford departed as Chief Executive Officer, Pharmaceutical Segment at CARDINAL HEALTH INC.
  - Action: ceased to serve
  - Role: Chief Executive Officer, Pharmaceutical Segment
  source text: On September 8, 2022, Cardinal Health, Inc. (the “Company”) announced that Victor L. Crawford will cease to serve as Chief Executive Officer, Pharmaceutical Segment effective September 19, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137122000101/0000721371-22-000101-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.